BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35093935)

  • 1. The oncogenic role of treacle ribosome biogenesis factor 1 (
    Gu W; Sun L; Wang J; Chen X
    Aging (Albany NY); 2022 Jan; 14(2):943-960. PubMed ID: 35093935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC.
    Wu C; Xia D; Wang D; Wang S; Sun Z; Xu B; Zhang D
    Cancer Sci; 2022 Feb; 113(2):553-564. PubMed ID: 34904330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of
    Grzanka M; Piekiełko-Witkowska A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar protein treacle ribosome biogenesis factor 1 maintains gastric cancer cell proliferation by regulating R-loop associated DNA replication stress.
    Nie X; Zhao C; Zhang Y; Huang W; Zhou Y; Liu H; Nie Y; Xie K; Jia L
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1170-1180. PubMed ID: 36941105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
    Dixon J; Jones NC; Sandell LL; Jayasinghe SM; Crane J; Rey JP; Dixon MJ; Trainor PA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13403-8. PubMed ID: 16938878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
    Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
    Front Genet; 2022; 13():993438. PubMed ID: 36685895
    [No Abstract]   [Full Text] [Related]  

  • 7. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomewide analysis of gene expression associated with Tcof1 in mouse neuroblastoma.
    Mogass M; York TP; Li L; Rujirabanjerd S; Shiang R
    Biochem Biophys Res Commun; 2004 Dec; 325(1):124-32. PubMed ID: 15522210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mutations in ribosomal biogenesis gene TCOF1 identified in human neural tube defects.
    Wang F; Cheng H; Zhang Q; Guo J
    Mol Genet Genomic Med; 2023 May; 11(5):e2150. PubMed ID: 36808708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the Expression and Prognostic Value of MSH2 in Pan-Cancer Based on Bioinformatics.
    Qiu W; Ding K; Liao L; Ling Y; Luo X; Wang J
    Biomed Res Int; 2021; 2021():9485273. PubMed ID: 34859104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma.
    Wei S; Lu K; Xing J; Yu W
    FASEB J; 2023 Apr; 37(4):e22849. PubMed ID: 36884358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treacle is Upregulated in Cancer and Correlates With Poor Prognosis.
    Oxe KC; Larsen DH
    Front Cell Dev Biol; 2022; 10():918544. PubMed ID: 35794866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tcof1-Related Molecular Networks in Treacher Collins Syndrome.
    Dai J; Si J; Wang M; Huang L; Fang B; Shi J; Wang X; Shen G
    J Craniofac Surg; 2016 Sep; 27(6):1420-6. PubMed ID: 27300466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
    Hu J; Qiu D; Yu A; Hu J; Deng H; Li H; Yi Z; Chen J; Zu X
    Front Oncol; 2021; 11():607224. PubMed ID: 34026603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers.
    Peng L; Li J; Wu J; Xu B; Wang Z; Giamas G; Stebbing J; Yu Z
    Front Immunol; 2021; 12():762598. PubMed ID: 34675941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of ribonucleotide reductase subunit M2 for carcinogenesis in pan-cancer.
    Wang Y; Chen R; Zhang J; Zeng P
    PLoS One; 2024; 19(4):e0299949. PubMed ID: 38635758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pan-Cancer Crosstalk Between the
    Xie R; Yuan M; Jiang Y
    Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
    [No Abstract]   [Full Text] [Related]  

  • 19. Treacher Collins syndrome: unmasking the role of Tcof1/treacle.
    Sakai D; Trainor PA
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1229-32. PubMed ID: 19027870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
    Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
    Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.